Cedric Francois - Jan 20, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Executive Officer, Director
Signature
/s/ David Watson, attorney-in-fact for Cedric Francois
Stock symbol
APLS
Transactions as of
Jan 20, 2023
Transactions value $
-$492,029
Form type
4
Date filed
1/24/2023, 04:17 PM
Previous filing
Jan 17, 2023
Next filing
Jan 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability -$492K -9.45K -0.9% $52.05 1.04M Jan 20, 2023 Direct F1
holding APLS Common Stock 300K Jan 20, 2023 Indirect Owner (The Francois Grossi Trust) F2
holding APLS Common Stock 234K Jan 20, 2023 Indirect Owner (The Francois-DuBois Educational Trust) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares withheld for tax on a restricted stock unit release.
F2 The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
F3 The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.